Hrain Biotechnology Co., Ltd.: Observational study in B-Cell Non-Hodgkin Lymphoma (NHL) (200 participants)
Hrain Biotechnology Co., Ltd.: Observational study in B-Cell Non-Hodgkin Lymphoma (NHL) (200 participants). Its enrollment of 200 is above the median of 80 (77th percentile). Dated 13 days ago, it is in the active follow-up window. Score 85/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 200 · 77th percentile of 8,879 ClinicalTrialStartPulse records · 2.5x the median
Free preview: all 13 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Hrain Biotechnology Co., Ltd. |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | Non-Interventional Study of Ranicabtagene Autoleucel Injection for Relapsed/Refractory B-cell Non-Hodgkin Lymphoma |
| NCT ID | NCT07888530 |
| Phase | Observational |
| Status | not yet recruiting |
| Conditions | B-Cell Non-Hodgkin Lymphoma (NHL) |
| Intervention types | drug |
| Target enrollment | 200 |
| Posted | 2026-10-22 |
| Planned start | 2026-10-30 |
| Event | Newly registered study |
| Event date | 2026-10-22 |
| enrollment percentile | 77th of 8,879 (median 80, 2.5x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Hrain Biotechnology Co., Ltd.
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock Hrain Biotechnology Co. + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-22
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Hrain Biotechnology Co., Ltd. and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- Hrain Biotechnology Co., Ltd.'s enrollment: 77th percentile of 8,879 records
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
85 / 100 Score
- Posted in the last two weeks.
- Industry sponsor (buys outsourced services).
- 200 participants planned.
- Not yet recruiting: vendors still being chosen.
What is the ClinicalTrialStartPulse record for Hrain Biotechnology Co., Ltd.?
Hrain Biotechnology Co., Ltd. registered a Observational study (NCT07888530) in B-Cell Non-Hodgkin Lymphoma (NHL) targeting 200 participants, posted 2026-10-22.
How does Hrain Biotechnology Co., Ltd. compare to other ClinicalTrialStartPulse records?
Its enrollment of 200 sits in the upper half (77th percentile) of 8,879 records; the median is 80. It is fresh: dated 13 days ago, inside the window where early outreach matters most. Its Score of 85/100 puts it among the stronger signals in this feed.
Hrain Biotechnology Co., Ltd. vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Hrain Biotechnology Co., Ltd. | NONUS | 200 | 77th | 2026-10-22 |
| Janssen-Cilag International NV | NONUS | 135 | 68th | 2026-11-03 |
| Janssen Pharmaceutica N.V., Belgium | NONUS | 1,314 | 95th | 2026-11-03 |
| Hoffmann-La Roche | NONUS | 1,800 | 96th | 2026-10-30 |
Related records
ClinicalTrialStartPulse: Observational ClinicalTrialStartPulse: Outside the US only
How to monitor Hrain Biotechnology Co., Ltd. and peer observational records
Get new ClinicalTrialStartPulse records like Hrain Biotechnology Co., Ltd. by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.